Moreover, genetic background was found to influence 18F-FDG PET findings in ALS, as hypometabolism in frontotemporal regions, basal ganglia, and thalami could be detected in patients carrying a C9orf72 gene expansion since the presymptomatic stages [321]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.